Differences in mechanisms of modulation between rat liver cholesterol 7α-hydroxylase and HMG-CoA reductase  by Lidström-Olsson, Bodil
Volume 189, number 1 FEBS 2874 September 1985 
Differences in mechanisms of modulation between rat liver 
cholesterol k-hydroxylase and HMG-CoA reductase 
Bodil Lidstriim-Olsson 
Department of Pharmacedcal Biochemistry, University of Uppsala, Uppsakz, Sweden 
Received 24 June 1985 
The effects of microsomal HMG-CoA reductase kinase, cytosolic phosphoprotein phosphatase and cyto- 
solic, thioldependent cholesterol ‘la-hydroxylase stimulatory protein on purified cholesterol 7a-hydroxylase 
and HMG-CoA reductase from rat liver were compared. Neither HMG-CoA reductase kinase nor phospho- 
protein phosphatase had any significant effect on cholesterol 7a-hydroxylase activity. They inhibited and 
stimulated, respectively, the activity of HMG-CoA reductase. The purified cytosolic protein which stimulat- 
ed cholesterol ‘la-hydroxylase threefold in the presence of glutathione had no effect on HMG-CoA reduc- 
tase. The results show that there are separate intracellular systems for modulation of cholesterol 7a-hydrox- 
ylase and HMG-CoA reductase. 
Cholesterol 7a-hydroxyase HMG-CoA reduetase 
1, INTRODUCTION 
Cholesterol 7cu-hydroxylation is the initial and 
major rate-limiting step in the conversion of 
cholesterol into bile acids [ 11. The reaction is 
catalyzed by a microsomal monooxygenase system 
involving cytochrome P-450 and NADPH- 
cytochrome P-450 reductase [2]. Sulfhydryl groups 
are important for the catalytic activity [3] and the 
modulation of cholesterol 7cu-hydroxylase by a 
cytosolic, ~iol~e~ndent protein has been recent- 
ly reported 141. 
Contradictory reports have appeared concerning 
the existence of a phosphorylation-dephosphoryla- 
tion mechanism for regulation of cholesterol 7~ 
hydroxylase [4-81. Reversible phosphorylation is 
involved in short-term regulation of another 
microsomal enzyme, HGM-CoA reductase, cata- 
lyzing the rate-limiting step in cholesterol biosyn- 
thesis [9, lo]. Cholesterol 7cu-hydroxylase and 
HMG-CoA reductase are in many instances re- 
Abbrevhztion: HGM-CoA, 3-hydroxy-3-methylglut~l 
coenzyme A 
Kinase Phosphoprotein phosphatase Glutathione 
gulated by the same factors, including hormonal 
and nutritional status as well as the concentration 
of bile acids in portal blood [ 11. In addition, it has 
been recently reported that sulfhydryl groups are 
important for catalytic activity also of HMG-CoA 
reductase [l I]. It should therefore be of interest o 
compare the effects of HMG-CoA reductase 
kinase, phosphoprotein phosphatase and 
cytosolic, thiol-dependent cholesterol 7a-hydroxyl- 
ase stimulatory protein on the two rate-limiting 
enzymes. The present communication reports such 
a study with purified cholesterol 7cu-hydroxylase 
and HMG-CoA reductase from rat liver micro- 
somes . 
2. MATERIALS AND METHODS 
2.1. Materials 
DL-3-hydroxy-3-[met~y~-yl-3H]methylglutaryl- 
CoA was obtained from New England Nuclear 
(12.2 Ci/mol), [4-r4C]choiesterol (61 Ci/mol) was 
obtained from the Radioche~c~ Center, Amer- 
sham, England. Sephadex G-100 and Sephadex 
G-75 were from Pharmacia. 
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2.2. Methods 
Cytochrome P-450 active in cholesterol 7~ 
hydroxylation was prepared from liver microsomes 
of cholestyramine-treated rats as described [ 121. 
NADPH-cytochrome P-450 reductase (spec. act. 
50 units per mg) was prepared from phenobarbital- 
treated rats according to Yasukochi and Masters 
1131. 
HMG-CoA reductase was prepared from liver 
microsomes of cholestyramine-treated rats, was 
solubilized as described by Edwards et al. [14] and 
precipitated with ammonium sulfate (35-50%) 
v51. 
Phosphoprotein phosphatase from liver of un- 
treated rats was prepared as described by Titanji 
[16], with the exception that the 100000 x g super- 
natant was used as starting material instead of the 
16000 x g supernatant. Sephadex G-100 
chromatography was used instead of Sepharose 6B 
chromatography in the last purification step. 
Microsomal HMG-CoA reductase kinase was 
prepared from untreated rats according to Ferrer 
and Hegardt [17]. 
Cytosolic cholesterol 7a-hydroxylase stimulato- 
ry protein was purified as described by Danielsson 
et al. [4] with the exception that the isoelectric 
focusing step was replaced by Sephadex G-75 chro- 
matography. The protein obtained after this modi- 
fication of the purification procedure showed one 
protein band (Mr = 25000) upon polyacrylamide 
gel electrophoresis in the presence of SDS. 
2.3. Incubation procedures and analyses of 
incubation mixtures 
Incubations with cholesterol were performed at 
37°C for 20 min in a total volume of 0.75 ml of 
Tris-acetate buffer, pH 7.4, containing 20% 
glycerol. The incubation mixture contained 
0.1 nmol cytochrome P-450, 0.5 units NADPH- 
cytochrome P-450 reductase, 15 ,ug dilauroylgly- 
cero-3-phosphorylcholine, 0.3 mg Triton X-100 in 
20~1 water, 0.5 pmol reduced glutathione or 
2 pmol dithiothreitol, 25 nmol cholesterol added 
in 15 ~1 acetone, and 0.9 pmol NADPH. The in- 
cubations were terminated and analyzed for 
cholesterol 7a-hydroxylase activity as described 
]21. 
Incubations with HMG-CoA reductase were 
performed at 37°C for 20 min in a total volume of 
150~1 of 50 mM Tris-Cl buffer, pH 6.8, contain- 
ing 0.2 M KCl. The incubation mixture contained 
95 pg HMG-CoA reductase, 0.75 pmol dithio- 
threitol, 50 nmol HMG-CoA and 0.45 ,umol 
NADPH. The incubations were terminated by 
addition of 25-50~1 of 10 M HCl, shaken vigo- 
rously and incubated for 20 min at 37°C to allow 
complete lactonization of mevalonic acid. HMG- 
CoA reductase activity was assayed by the mixed- 
phase assay described by Philipp and Shapiro [ 181. 
In experiments on the effect of phosphoprotein 
phosphatase on cholesterol 7cu-hydroxylase and 
HMG-CoA reductase, appropriate amounts of 
phosphatase were preincubated at 37°C for 60 min 
with cytochrome P-450 or HMG-CoA reductase 
and 0.75 pmol dithiothreitol in a volume of 95 pl 
of 50 mM Tris-Cl buffer, pH 6.8, containing 
0.2 M KCl. After preincubation, 11 pmol NaF 
were added together with cofactors and substrates 
and the activities were analyzed as described 
above. 
In experiments on the effect of HMG-CoA 
reductase kinase, cytochrome P-450 or HMG-CoA 
reductase were preincubated with appropriate 
amounts of kinase as described for homogeneous 
HMG-CoA reductase by Ferrer and Hegardt [ 171. 
Cytochrome P-450 or HMG-CoA reductase, 
kinase, 0.45 pmol dithiothreitol, and 20~1 of a 
6 : 20 mM ATP/MgClz solution were preincubated 
at 37°C for 60 min. After preincubation, 20 ,ul of 
40 mM KHzP04 buffer, pH 7.2, containing 
25 mM sucrose, 100 mM NaF, 30 mM EDTA, and 
1 mM dithiothreitol, were added with the other 
components and the activities were analyzed as 
described above. 
In experiments on the effect of purified cytosolic 
cholesterol 7a-hydroxylase stimulatory protein on 
cholesterol 7a-hydroxylase and HMG-CoA reduc- 
tase, appropriate amounts of cytosolic protein 
were first preincubated with 0.1 pm01 
dithiothreitol for 20 min and then with glutathione 
and cytochrome P-450 or HMG-CoA reductase for 
20 min at 37°C in a volume of 150~1 Tris-acetate 
buffer, pH 7.4, containing 20% glycerol. After 
preincubation, cofactors and substrate were added 
to cholesterol incubations as described above. To 
make incubations with HMG-CoA reductase com- 
parable to those with cholesterol 7cu-hydroxylase, 
0.12 mg Triton X-100 in water, 688 dilauroylgly- 
cero-3-phosphorylcholine, 100 nmol HMG-CoA 
and 0.6pmol NADPH were added to a final 
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volume of 260~1. Incubations were run at 37°C 
for 20 min and were terminated and analyzed for 
HMG-CoA reductase activity as described above. 
3. RESULTS 
Cytochrome P-450 catalyzing 7cr-hydroxylation 
of cholesterol and HMG-CoA reductase were in- 
cubated with microsomal HMG-CoA reductase 
kinase, cytosolic phosphoprotein phosphatase and 
cytosolic cholesterol 7Eu-hydroxylase stimulatory 
protein under the same conditions. Fig.1 shows 
that preincubation of increasing amounts of 
microsomal HMG-CoA reductase kinase and 
ATP/MgClz with cholesterol 7a-hydroxylase had 
no effect on the 7cu-hydroxylation of cholesterol. 
The HMG-CoA reductase kinase had the expected 
inactivating effect on HMG-CoA reductase. A 
90% loss of activity was seen in the presence of 
50rg kinase and ATP/MgCL. 
10 30 5t 
HMG-CoAreductase klnase(w) 
Fig.1. Effect of HMG-CoA reductase kinase on 
cholesterol 7cu-hydroxylase and HMG-CoA reductase 
activities. Incubations were performed in the presence of 
ATP and MgC12 as described in section 2. (0) 
Cholesterol 7a-hydroxylase activity; (0) HMG-CoA 
reductase activity. Activities are expressed as 
percentages of control values. 100% cholesterol 7~ 
hydroxylase activity corresponds to 285 pmol 7~ 
hydroxycholesterol formed per nmol cytochrome P-450 
and min. 100% HMG-CoA reductase activity 
corresponds to 2.25 nmol mevalonic acid formed per mg 
Fig.2. Effect of phosphoprotein phosphatase on 
cholesterol 7a-hydroxylase and HMG-CoA reductase 
activities. Incubation conditions were as described in 
section 2. (0) Cholesterol 7cu-hydroxylase activity; (0) 
HMG-CoA reductase activity. Activities are expressed as 
percentages of control values. 100% cholesterol 7~ 
hydroxylase activity corresponds to 290 pmol 7~ 
hydroxycholesterol formed per nmol cytochrome P-450 
and min. 100% HMG-CoA reductase activity 
corresponds to 2.25 nmol mevalonic acid formed per mg 
protein and min. protein and min. 
Fig.2 shows that preincubation of increasing 
amounts of phosphoprotein phosphatase with 
cholesterol 7tu-hydroxylase had no effect on 7~ 
hydroxylation of cholesterol. Increasing amounts 
of phosphoprotein phosphatase in the preincuba- 
tion mixture stimulated HMG-CoA reductase 
twofold and then remained constant. Maximal 
stimulation was obtained with 5 pg of 
phosphatase. 
Fig.3A shows that preincubation of cholesterol 
7a-hydroxylase stimulatory protein (50 pg) with 
cholesterol 7a-hydroxylase and increasing concen- 
trations of glutathione stimulated the conversion 
of cholesterol into 7a-hydroxycholesterol. A three- 
fold stimulation was obtained with 0.5-l mM 
glutathione. The protein had no stimulatory effect 
in the absence of glutathione. As reported [4] 
glutathione also stimulated cholesterol 7~ 
hydroxylation in the absence of stimulatory pro- 
tein. However, the degree of stimulation was less 
250; 
I 
5 15 25 
Phosphoprotein phosphatase (pg ) 
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1 
Giutathione (mki) 
1 
Glutathione (mM 1 
than in the presence of the ~t~rn~a~~~y protein. 
Fig.JB shows that ~re~n~~at~u~ of NMG-&A 
reductase tith choiesteru1 7~-hy~~o~~~a~e stim-
nlatory protein and glutathione had no effect on 
WEMG-CoA rednetase activity. 
- 
Fig3. (A) Effect of reduced @tathione and purified 
cytosolic holesterof 7~&ydrox@se stimulatory protein 
on cholesterol 7a-hydroxylase activity. Xncubation 
conditions wore as described insection 2. In experiments 
on the effect of purified cytosolic protein, 50 pg of this 
fraction were included in the incubation mixture. (0) 
Reduced glutathiane; (A) reduced glutathione in 
presence of cytosolic protein. Cholesterol 7~ 
hydroxylase &ctivity is expressed as percentage ofcoutrol 
values, 100% activity corresponds to 255 pmof 7~ 
hydroxycho~~te~~i formed per nmaf cytocbroma P450 
and min. (R) Effect of reduced g&an&one and purified 
cytosolic holesterol ~~~~~dr~~~~ ~~rn~~at~r~ p otejn 
on WMG-CoA redtnctase a&iv&y. Incubation conditions 
were as dcscritred in sectiou 2. Ln experiments on the 
effect of pudficd cytosolic protein, 50 pg of this fraction 
were included in the incubation mixture. (a) Reduced 
glutathione; (A) reduced glutathione in presence of 
cytosolic protain. HMG-CoA reductase activity is 
expressed as percentage of control values. 100970 HMO- 
CoA reductw activity corresponds to 1.2 umot of 
mevalanic acid formed per mg protein and min, 
Several recent reports in which whole 
microsomcs have been used as enzyme source sug- 
gest that cholesterol 7cu-hydroxylase is modulated 
by a reversible phosphorylation mechanism 1%71. 
The present results show that the activity of 
purified, reconstituted choIestero1 7+hydroxyXase 
system is not modnlated by a kinase and a 
phos~hat~s~ active on ETMG-CoA reductase. 
Thus, it appears fess Eke& that cholesterol 7@- 
hydruxy~ase is regnfated by a ~ho~~b#ry~ation- 
dephosph#~~~ation mechanism. However, tbe 
results da not exclude the existence of other pro- 
tein kinascs and phosphatases which act upon and 
even may be specific for cholestero) 7~ 
hydroxylase. 
The cytosolic cholesterol 7a-hydroxylase 
stimulatory protein had no effect on HMO-CoA 
reductase in presence of glutathione concentra- 
tions (W-2 mM) resulting in stimulation of 
cholesterol ~~-h~droxylase. As reported, glutathi- 
one alone had a ~~m~~atory effect on ~~o~e~tero~ 
7~~hydr~xy~a~e hhough smaller than that ob- 
served in the presence of the stimuIatory protein. 
Under the same conditions, giutathione aXone had 
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no effect on ~G~oA reductase activity. It 
should be mentions that HMG-CoA reductase is 
$ti~~l~t~ by ghS.&ione in concentrations 
10-f&d higher (W-20 mM) than those required for 
stimul&tion of cholesterol 7@-hydroxyltation [ 111. 
The results of the present communication in- 
dicate that short-term regulation of rat liver 
cholesterol 7cu-hydroxylase and HMG-CoA reduc- 
tase does not involve the same type of mechanism 
and that there are separate intraeellnlar 
m~~latory systems for these two re~~~a~ory en-
zymes in cholesterol rn~a~~~* 
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